Fucoidan extract derived from Undaria pinnatifida inhibits angiogenesis by human umbilical vein endothelial cells

Phytomedicine

Volumn 19, Issue 8-9, 2012, Pages 797-803

  Liu, Fang ^a   Wang, Jia ^a   Chang, Alan K ^b   Liu, Bing ^a   Yang, Lili ^a   Li, Qiaomei ^a   Wang, Peisheng ^a   Zou, Xiangyang ^a  

^a DALIAN MEDICAL UNIVERSITY   (China)

^b DALIAN UNIVERSITY OF TECHNOLOGY   (China)

Author keywords

Angiogenesis; Fucoidan; Human umbilical vein endothelial cells; Undaria pinnatifida; VEGF A

Indexed keywords

FUCOIDIN; VASCULOTROPIN A;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIANGIOGENIC ACTIVITY; ANTIPROLIFERATIVE ACTIVITY; ARTICLE; CAPILLARY TUBE; CELL CULTURE; CELL MIGRATION; CELL PROLIFERATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; DOSE RESPONSE; EX VIVO STUDY; FEMALE; HUMAN; HUMAN CELL; IN VITRO STUDY; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; UMBILICAL VEIN ENDOTHELIAL CELL; UNDARIA; UNDARIA PINNATIFIDA; VASCULAR RING;

ANGIOGENESIS INHIBITORS; ANIMALS; AORTA; APOPTOSIS; CELL MOVEMENT; CELL PROLIFERATION; DRUG EVALUATION, PRECLINICAL; FEMALE; HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS; HUMANS; NEOVASCULARIZATION, PHYSIOLOGIC; POLYSACCHARIDES; RATS; RATS, SPRAGUE-DAWLEY; UNDARIA; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

PHAEOPHYCEAE; UNDARIA PINNATIFIDA;

EID: 84861818270     PISSN: 09447113     EISSN: 1618095X     Source Type: Journal    
DOI: 10.1016/j.phymed.2012.03.015     Document Type: Article

References (44)

1. T. Alon, I. Hemo, A. Itin, J. Pe'er, J. Stone, and E. Keshet Vascular endothelial growth factor acts as a survival factor for newly formed retinal vessels and has implications for retinopathy of prematurity Nat. Med. 1 1995 1024 1028
2. 2 Biol. Chem. 274 1999 35562 35570
3. F. Bussolino, A. Mantovani, and G. Persico Molecular mechanisms of blood vessel formation Trends Biochem. Sci. 22 7 1997 25l 256l
4. E. Chavakis, and S. Dimmeler Regulation of endothelial cell survival and apoptosis during angiogenesis Arterioscler. Thromb. Vasc. Biol. 22 2002 887 893
5. M.L. Cho, B.Y. Lee, and S.G. You Relationship between oversulfation and conformation of low and high molecular weight fucoidans and evaluation of their in vitro anticancer activity Molecules 16 2011 291 297
6. P.F. Dias, J.M. Siqueira Jr., L.F. Vendruscolo, TdJ. Neiva, A.R. Gagliardi, M. Maraschin, and R.M. Ribeiro-do-Valle Antiangiogenic and antitumoral properties of a polysaccharide isolated from the seaweed Sargassum stenophyllum Cancer Chemother. Pharmacol. 56 2005 436 446
7. N. Ferrara Vascular endothelial growth factor Trends Cardiovasc. Med. 3 1993 244 250 Science 109, 227-241
8. N. Ferrara, H.P. Gerber, and J. LeCouter The biology of VEGF and its receptors Nat. Med. 9 2003 669 676
9. N. Ferrara, and R. Kerbel Angiogenesis as a therapeutic target Nature 438 2005 967 974
10. J. Folkman Tumor angiogenesis: therapeutic implications N. Engl. J. Med. 285 1971 1182 1186
11. J. Folkman Tumor angiogenesis Adv. Cancer Res. 19 1974 331 358
12. J. Folkman, and Y. Shing Angiogenesis J. Biol. Chem. 267 1992 10931 10934
13. P. Ganesan, K. Matsubara, T. Ohkubo, Y. Tanaka, K. Noda, T. Sugawara, and T. Hirata Anti-angiogenic effect of siphonaxanthin from green alga, Codium fragile Phytomedicine 17 2010 1140 1144
14. D. Hanahan, G. Christofori, P. Naik, and J. Arbeit Transgenic mouse models of tumour angiogenesis: the angiogenic switch, its molecular controls, and prospects for preclinical therapeutic models Eur. J. Cancer 32A 14 1996 2386 2393
15. D. Hanahan, and J. Folkman Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis Cell 86 1996 353 364
16. H. Hlawaty, N. Suffee, A. Sutton, O. Oudar, O. Haddad, V. Ollivier, C.L. Morizot, L. Gattegno, D. Letourneur, and N. Charnaux Low molecular weight fucoidan prevents intimal hyperplasia in rat injured thoracic aorta through the modulation of matrix metalloproteinase-2 expression Biochem. Pharmacol. 81 2011 233 243
17. K.A. Houck, N. Ferrara, J. Winer, G. Cachianes, B. Li, and D.W. Leung The vascular endothelial growth factor family: identification of a fourth molecular species and characterization of alternative splicing of RNA Mol. Endocrinol. 5 1991 1806 1814
18. E.J. Kim, S.Y. Park, J.Y. Lee, and J.H.Y. Park Fucoidan present in brown algae induces apoptosis of human colon cancer cells BMC Gastroenterol. 10 2010 96
19. M. Klagsbrun, and P.A. D'Amore Regulators of angiogenesis Annu. Rev. Physiol. 53 1991 217 239
20. S. Koyanagi, N. Tanigawa, H. Nakagawa, S. Soeda, and H. Shimeno Oversulfation of fucoidan enhances its anti-angiogenic and antitumor activities Biochem. Pharmacol. 65 2003 173 179
21. 165 bingding to VEGF-2 and NRP1 Biol. Chem. 281 2006 37844 37852
22. A.P. Levy, N.S. Levy, S. Wegner, and M.A. Goldberg Transcriptional regulation of the rat vascular endothelial growth factor gene by hypoxia Biol. Chem. 270 1995 13333 13340
23. K. Lgarashi, K. Shigeta, T. Isohara, T. Yamano, and I. Uno Sck interacts with KDR and Flt-1 via its SH2 domain Biochem. Biophys. Res. Commun. 251 1998 77 82
24. P. Lindhal, B.E. Johansson, P. Leveen, and C. Betsholtz Pericyte loss and microaneurysm formation in PDGF-B deficient mice Science 277 1997 242 245
25. K. Matsubara, M. Mori, H. Matsumoto, K. Hori, and K. Miyazawa Antiangiogenic properties of a sulfated galactan isolated from a marine green alga, Codium cylindricum J. Appl. Phycol. 15 2003 87 90
26. Y. Matsuda, K. Teruya, S. Matsuda, A. Nakano, T. Nishimoto, M. Ueno, A. Niho, M. Yamashita, H. Eto, and Y. Katakura Anti-cancer effect of enzyme-digested fucoidan extract from seaweed Mozuku Anim. Cell Technol. 16 2010 295 300
27. S. Mori, C. Wu, S. Yamaji, J. Saegusa, B. Shi, Z. Ma, Y. Kuwabara, K.S. Lam, R.R. Isseroff, Y.K. Takada, and Y. Takada Direct binding of integrin αvβ3 plays a role in FGF1 signaling Biol. Chem. 283 2008 18066 18075
28. N.J. Nelson Inhibitors of angiogenesis enter phase III testing J. Natl. Cancer Inst. 90 1998 960 963
29. G. Neufeld, T. Cohen, S. Gengrinovitch, and Z. Poltorak Vascular endothelial growth factor (VEGF) and its receptors FASEB 13 1999 9 22
30. R.F. Nicosia, and A. Ottinetti Growth of microvessels in serum-free matrix culture of rat aorta. A quantitative assay of angiogenesis in vitro Lab. Invest. 63 1990 115 122
31. R.F. Nicosia, and A. Ottinetti Modulation of microvascular growth and morphogenesis by reconstituted basement membrane gel in three-dimensional cultures of rat aorta: a comparative study of angiogenesis in matrigel, collagen, fibrin, and plasma clot In Vitro Cell Dev. Biol. 26 1990 119 128
32. M.S. O'Reilly The preclinical evaluation of angiogenesis inhibitors Invest. New Drugs 15 1997 5 13
33. M. Relf, S. LeJeune, P.A. Scott, S. Fox, K. Smith, R. Leek, A. Moghaddam, R. Whitehouse, R. Bicknell, and A.L. Harris Expression of the angiogenic factors vascular endothelial cell growth factor, acidic and basic fibroblast growth factor, tumor growth factor β-1, platelet-derived endothelial cell growth factor, placenta growth factor, and pleiotrophin in human primary breast cancer and its relation to angiogenesis Cancer Res. 57 1997 963 969
34. A.M. Romanic, C.L. Burns-Kurtis, B. Gout, I. Berrebi-Bertrand, and E.H. Ohlstein Matrix metalloproteinase expression in cardiac myocytes following myocardial infarction in the rabbit Life Sci. 68 2001 799 814
35. S. Rousseau, F. Houle, and J. Huot Integrating the VEGF signals leading to actin-based motility in vascular endothelial cells Trends Cardiovasc. Med. 10 2000 321 327
36. S. Rousseau, F. Houle, H. Kotanides, L. Witte, J. Waltenberger, J. Landry, and J. Huot Vascular endothelial growth factor (VEGF)-driven actin-based motility is mediated by VEGFR2 and requires concerted activation of stress-activated protein kinase 2(SAPK2/p38) and geldanamycin-sensitive phosphorylation of focal adhesion kinase J. Biol. Chem. 275 2000 10661 10672
37. L. Smolej, C. Andrys, V. Maisnar, L. Pour, and J. Maly Plasma concentrations of vascular growth factor and basic fibroblast growth factor in lyrephoproliferative disorders Acta Med. (Hradec Kralove) 48 1 2005 57 58
38. H.Y. Takahashi, and M.B. Shibuya The vascular endothelial growth factor (VEGF)/VEGF receptor system and its role under physiological and pathological conditions Clin. Sci. 109 2005 227 241
39. A.J. Wamer, J. LoPez-Dee, E.L. Knight, J.R. Feramisco, and S.A. Prigent The Shc-related adaptor protein. Sck, forms a complex with the vascular-endothelia-growth-factor receptor KDR in transfected cells Biochem. J. 347 2000 501 509
40. Z.P. Xu, F.C. Li, and H.R. Wang Anti-angiogenic and anti-tumor activity of LAMS Chin. Tradit. Herb. Drugs 30 1999 551 553
41. G.D. Yancopoulos, S. Davis, N.W. Gale, J.S. Rudge, S.J. Wiegand, and J. Holash Vascular-specific growth factors and blood vessel formation Nature 407 2000 242 248
42. J. Ye, Y.P. Li, K. Teruya, Y. Katakura, A. Ichikawa, H. Eto, M. Hosoi, M. Hosoi, S. Nishimoto, and S. Shirahata Enzyme-digested fucoidan extracts derived from seaweed Mozuku of Cladosiphon novae-caledoniae kylin inhibit invasion and angiogenesis Cytotechnology 47 2005 117 126
43. S.G. You, C. Yang, H.Y. Lee, and B.Y. Lee Molecular characteristics of partially hydrolyzed fucoidans from sporophyll of Undaria Pinnatifida and their in vitro anticancer activity Food Chem. 119 2010 554 559
44. C. Zhang, F. Yang, X.W. Zhang, S.C. Wang, M.H. Li, L.P. Lin, and J. Ding Grateloupia longifolia polysaccharide inhibits angiogenesis by downregulating tissue factor expression in HMEC-1 endothelial cells Br. J. Pharmacol. 148 2006 741 751